Differential impact of doxorubicin dose on cell death and autophagy pathways during acute cardiotoxicity
P Kawalec, MD Martens, JT Field, W Mughal… - Toxicology and Applied …, 2022 - Elsevier
Doxorubicin (DOX) is an effective anthracycline used in chemotherapeutic regimens for a
variety of haematological and solid tumors. However, its utility remains limited by its well …
variety of haematological and solid tumors. However, its utility remains limited by its well …
[PDF][PDF] Differential Impact of Doxorubicin Dose on Cell Death and Autophagy Pathways during Acute Cardiotoxicity.
P Kawalec, MD Martens, JT Field, W Mughal, A Miguel… - scholar.archive.org
Doxorubicin (DOX) is an effective anthracycline used in chemotherapeutic regimens for a
variety of haematological and solid tumors. However, its utility remains limited by its …
variety of haematological and solid tumors. However, its utility remains limited by its …
Differential impact of doxorubicin dose on cell death and autophagy pathways during acute cardiotoxicity.
P Kawalec, MD Martens, JT Field… - Toxicology and …, 2022 - europepmc.org
Doxorubicin (DOX) is an effective anthracycline used in chemotherapeutic regimens for a
variety of haematological and solid tumors. However, its utility remains limited by its well …
variety of haematological and solid tumors. However, its utility remains limited by its well …
Differential impact of doxorubicin dose on cell death and autophagy pathways during acute cardiotoxicity
P Kawalec, MD Martens, JT Field… - Toxicology and …, 2022 - ui.adsabs.harvard.edu
Doxorubicin (DOX) is an effective anthracycline used in chemotherapeutic regimens for a
variety of haematological and solid tumors. However, its utility remains limited by its well …
variety of haematological and solid tumors. However, its utility remains limited by its well …
Differential Impact of Doxorubicin Dose on Cell Death and Autophagy Pathways during Acute Cardiotoxicity
P Kawalec, MD Martens, JT Field, W Mughal… - bioRxiv, 2022 - biorxiv.org
Doxorubicin (DOX) is an effective anthracycline used in chemotherapeutic regimens for a
variety of haematological and solid tumors. However, its utility remains limited by its well …
variety of haematological and solid tumors. However, its utility remains limited by its well …
Differential impact of doxorubicin dose on cell death and autophagy pathways during acute cardiotoxicity
P Kawalec, MD Martens, JT Field… - Toxicology and …, 2022 - pubmed.ncbi.nlm.nih.gov
Doxorubicin (DOX) is an effective anthracycline used in chemotherapeutic regimens for a
variety of haematological and solid tumors. However, its utility remains limited by its well …
variety of haematological and solid tumors. However, its utility remains limited by its well …
[引用][C] Differential impact of doxorubicin dose on cell death and autophagy pathways during acute cardiotoxicity
P Kawalec, MD Martens, JT Field, W Mughal… - Toxicology and Applied …, 2022 - cir.nii.ac.jp
Differential impact of doxorubicin dose on cell death and autophagy pathways during acute
cardiotoxicity | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …
cardiotoxicity | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …
Differential Impact of Doxorubicin Dose on Cell Death and Autophagy Pathways during Acute Cardiotoxicity
P Kawalec, MD Martens, JT Field, W Mughal… - 2022 - europepmc.org
Doxorubicin (DOX) is an effective anthracycline used in chemotherapeutic regimens for a
variety of haematological and solid tumors. However, its utility remains limited by its well …
variety of haematological and solid tumors. However, its utility remains limited by its well …